Published by Josh White on 3rd November 2025
(Sharecast News) - Hutchmed unveiled new details on its expanding oncology pipeline and research strategy, including the launch of its next-generation antibody-targeted therapy conjugate (ATTC) platform, during its annual research and development update on Monday.
URL: http://www.digitallook.com/dl/news/story/35467908/...